ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING. Mediterr J Hematol Infect Dis 2018, 10 (1), e2018014. https://doi.org/10.4084/mjhid.2018.014.